University of Arkansas for Medical Sciences

Brachytherapy (BT) remains the standard modality for dose escalation in cervical cancer boost targets, with well-established high-dose-rate (HDR) EQD2 constraints based on HR-CTV D90 and organ-at-risk (OAR) D2cc metrics. However, BT is not feasible for all pa...

This study evaluates a commercial web-based AI model for auto-segmentation of pelvic sites by comparing its contours to expert ground truth and an alternative AI model, emphasizing its accuracy and clinical relevance for radiotherapy planning.

To commission and clinically implement a robust radiochromic film dosimetry workflow for PBS proton therapy, providing a practical solution for small-field patient-specific QA, in-vivo dose verification, and WET-based range assessment when dedicated in-vivo a...

To assess dual-layer DECT-derived SPR images for proton therapy by identifying tissue-specific deviations versus SECT, validating discrepancies using measured SPR in biological tissues, and evaluating dosimetric impact of DECT-based robust optimization.